ClinicalTrials.gg
Active, not recruitingNCT05389865Updated Jul 15, 2024

Proximal Aortopathy in Scotland - Epidemiology and Surgical Outcomes

An observational study in Aortic Diseases, Aortic Dissection and Aortic Aneurysm, Thoracic, sponsored by Golden Jubilee National Hospital. Active, not recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-15.

Sponsored by Golden Jubilee National Hospital · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,662
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Aortic Diseases with a site in United Kingdom — 4 open to participants now, 6 under way, none of them phase 3. Aortic Diseases · United Kingdom.

Started
2023
with 1 other
Observational
8 of 13
3 open now
Registered
11th of 13
by date
Lead sponsor
1 of 13
Golden Jubilee National Hospital

Among the 13 studies in Aortic Diseases with a site in United Kingdom, this one is one of 2 that started in 2023, is one of 8 observational ones, and was the 11th registered.

Aortic Diseases

109 studies on the registry are indexed under Aortic Diseases; 44 are open to participants now.

Browse Aortic Diseases studies →

Open to participants now

4 of the 13 studies in Aortic Diseases with a site in United Kingdom are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 36 Aortic Diseases studies recruiting now, 28 (78%) set no upper age limit and 2 (6%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.

This study: 18 Years and older · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Aortic Diseases with a site in United Kingdom, or all of them as a file.
02

Study summary

The aorta is the principal arterial vessel arising from the left heart that transfers blood to the body. Certain genetic and familial disease processes are known to weaken the aortic wall resulting in dilation and potential rupture. These aortic complications carry high mortality (>25%) and current management is orientated towards early detection and preventive treatment. Aortic dilation can also result in aortic valve dysfunction leading to heart failure. The estimated UK incidence of aortic disease per year is around 10 per 100,000 individuals, with 2000 people per year dying from aortic complications.

The 2017-2020 National Adult Cardiac Surgery Audit report identified the number of people receiving surgery for aortic dissection in Scotland is per population proportionately lower compared to England (4.6 per million per year in Scotland vs. 6.6 per million per year in England). The reasons for this are unclear but may relate to the prevalence of aortic disease or a large geographic distribution with compromised access to specialized centres.

Currently surgery is recommended when the aortic diameter exceeds a certain threshold. There are several types of effective surgical procedures, but there is still limited information on their long-term outcomes and the advantage of one procedure over another.

The aims of the project are firstly to determine the clinical outcomes of the surgical procedures that are currently employed in Scotland to treat proximal aortic disease and secondly to describe the prevalence and distribution of proximal aortic disease within the Scottish population. The project will be hosted by the Golden Jubilee Research Institute. Contemporary and retrospective data will be collected from all the Scottish Cardiothoracic Surgery units which are based in Glasgow, Edinburgh and Aberdeen.

This will be the first study to analyse surgical outcomes for ascending aortic disease in Scotland, and the first to describe the epidemiology of aortic disease within the population. It is anticipated that the results will guide current surgical practise, and provide data to inform national service provision for the management of proximal aortic disease.

Read the detailed description

The study has two principal aims:

  1. Determine the patient demographics, procedural types and related clinical outcomes in patients who underwent surgery of the proximal thoracic aorta in Scotland
  2. Describe the epidemiology of proximal aortopathy within the Scottish population, by determining the prevalence of disease, geographic distribution and patient demographics

This study will be the first to look at outcomes from a nation-wide cohort of patients following surgery of the thoracic aorta in the UK. The investigators anticipate that results from this study will inform future aortic practice and guide decisions on intervention timing and type.

Information on the prevalence and geographic distribution of aortic disease within Scotland will guide resource allocation and service configuration to allow equity in access to treatment. By raising awareness among the medical professionals and the wider community, the study should lead to improved recognition and better outcomes for patients with aortic disease.

Data will be recorded in a contemporary and retrospective manner for two patient cohorts:

  1. Surgical cohort - Adult patients who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen in the last 13 years (2008 - 2021).
  2. Non-surgical cohort - Adult patients who have a diagnosis of proximal aortopathy, but have not had surgery. This cohort will be obtained from three sources:

    1. Patients with a diagnosis of thoracic aortopathy identified via National Interim Clinical Imaging Procedure (NICIP) codes sourced from the Scottish Radiology Information System (RIS) and Picture Archive and Communication System (PACS) databases.
    2. Patients with a diagnosis of thoracic aortopathy identified from regional genetic services via the Network for Inherited Cardiac Conditions Scotland.
    3. Deceased patients diagnosed with proximal thoracic aortopathy or a complication thereof (aortic dissection, aortic rupture) registered at death certification and/or post mortem accessed from Public Health Scotland using ICD-10 codes.

The three data collection sites will be the Golden Jubilee National Hospital in Glasgow, the Edinburgh Royal Infirmary and Aberdeen Royal Infirmary.

The surgical cohort sample size is expected to be around 1300 patients. The non-surgical cohort is difficult to estimate, but around 500 cases yearly are expected to be identified. The research project will be hosted by the NHS Golden Jubilee Research Department.

The principal investigator (George Gradinariu) will undertake this research project as part of an postgraduate research programme (MD degree) at the University of Glasgow under the supervision of Professor Mark Danton (Congenital Cardiac Surgeon with interest in proximal aortic surgery), Professor Alex McConnachie Professor of Biostatistics, University of Glasgow) and Professor Faisal Ahmed (Samson Gemmell Chair of Child Health, University of Glasgow)

Statistical analysis will be overseen and supervised by Professor McConnachie. Descriptive statistics will be applied. Survival data will be analysed using Kaplan-Meier. Multivariable survival and logistic regression models will be used to identify variables predicting the risk of adverse outcomes. Predictive modelling to estimate the risk of adverse outcomes based on aortic root dimension will be assessed using ROC analysis. In comparing survival by procedures propensity matching will be used to minimize confounding. Analysis will be performed using R statistical analysis software (R Foundation for Statistical Computing, Vienna, Austria).

03

Conditions studied

  • Aortic Diseases
  • Aortic Dissection
  • Aortic Aneurysm, Thoracic
  • Aortic Ectasia
  • Aortic Valve Insufficiency
  • Bicuspid Aortic Valve
  • Marfan Syndrome
  • Ehlers-Danlos Syndrome
  • Loeys-Dietz Syndrome

Keywords

  • aortic surgery
  • aortic root
  • ascending aorta
  • surgical outcomes
  • thoracic aortopathy epidemiology
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

  1. Surgical cohort (Observational cohort design)- Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen.
  2. Non-surgical cohort (Cross-sectional design) - Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources:

    1. Scottish national radiological database based on specific imaging codes
    2. Regional genetic/inherited cardiac conditions services
    3. Public Health Scotland via specific diagnostic ICD-10 codes.

Eligibility criteria

Surgical cohort

Inclusion Criteria:

  • all adults (>18 years of age) that underwent surgical intervention on the proximal aorta in Scotland between 2008 and 2021.

Exclusion Criteria:

  • Isolated surgery on the descending thoracic aorta

Non-surgical cohort

Inclusion Criteria:

  • all adult patients (>18 years of age) with a radiological, genetic or post-mortem diagnosis of thoracic aortic disease
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,662 participants (actual)
Patient registry
No

Groups and cohorts

  • Surgical cohort

    Adult patients (18 years of age and above) who have had a surgical intervention on the proximal aorta in the three Scottish Cardiothoracic Surgery units based in Glasgow, Edinburgh, Aberdeen.

    Procedure: Surgery on the proximal aorta (aortic root +/- ascending aorta)

  • Non-surgical cohort

    - Adult patients (18 years of age and above) who have a diagnosis of proximal aortopathy, but have not had surgical intervention (non-surgical/un-intervened proximal aortopathy). This cohort will be obtained from three sources: 1. Scottish national radiological database based on specific imaging codes 2. Regional genetic/inherited cardiac conditions services 3. Public Health Scotland via specific diagnostic ICD-10 codes.

    Other: Patients diagnosed with thoracic aortopathy but not operated upon

Interventions

  • ProcedureSurgery on the proximal aorta (aortic root +/- ascending aorta)

    Surgery involving replacing, repairing or reinforcing the proximal aorta (root and ascending aorta)

  • OtherPatients diagnosed with thoracic aortopathy but not operated upon

    Radiological size criteria or Genetic mutations associated with aortopathies

06

What researchers measure

Primary outcomes

  1. Early survival following surgery of the proximal aorta

    In-hospital or 30 days survival following surgery of the proximal aorta

    Time frame: In-hospital or 30 days (whichever is longer)

  2. Late survival following surgery of the proximal aorta

    Long-term survival following surgery of the proximal aorta

    Time frame: 5 years or latest available follow-up (whichever is longer)

  3. Patient demographics and geographic distribution of thoracic aortopathy within the Scottish population

    Identify the demographics (age, gender, relevant risk factors) and geographic distribution (area codes) of patients diagnosed with thoracic aortopathy within the Scottish population

    Time frame: Cross-sectional analysis (2011-2021)

Secondary outcomes

  1. Cardiovascular reintervention

    Reinterventions (surgical/endovascular) related to the aortic implant or unoperated aorta Reintervention on Aortic valve (native or prosthesis)

    Time frame: 1 year or latest available follow-up (whichever is longer)

  2. Specified adverse events following surgery

    episodes of endocarditis, structural valve degeneration, thromboembolism, cerebral vascular accident, anticoagulant-related bleeding

    Time frame: 1 year or latest available follow-up (whichever is longer)

  3. Left ventricular ejection fraction (LVEF) following surgery

    Long-term left ventricular ejection fraction (\>50% - good, 31-50% - moderate, 21-30% - poor, 20% or less -very poor) as measured by echocardiography or cardiac MRI after surgery

    Time frame: 1 year or latest available follow-up (whichever is longer)

  4. Aortic valve mean gradient and degree of regurgitation following surgery

    Long-term aortic valve function as assessed by mean gradient (mmHg) and degree of regurgitation (mild/moderate/severe) in operated patients assessed by echocardiography or cardiac MRI

    Time frame: 1 year or latest available follow-up (whichever is longer)

  5. Genotypes and phenotypes prevalent in the Scottish population

    Identify genotypes and phenotypes in the Scottish population and assess their prevalence

    Time frame: Previous 5 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — To apply for further studies, beyond the current research, using the existing dataset, a research proposal submitted to the GJNH Research Department will be required. This will follow the established internal peer-review process established by the GJNH research department. If approved, a data request form will need to be submitted to the data custodian who will release the pseudo- anonymised data to the research applicant. If there is no request to extend the study then this data will be deleted.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Dec 2023 (actual). Primary completion is estimated for Aug 2025, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2022
First posted
May 25, 2022
StartActual
Dec 18, 2023
Primary completionEst.
Aug 2025
CompletionEst.
Aug 2025
Last update
Jul 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05389865
Lead sponsor
Golden Jubilee National Hospital
Collaborators
Aberdeen Royal Infirmary, Royal Infirmary of Edinburgh, Network for Inherited Cardiac Conditions Scotland, University of Glasgow
Responsible party
George Gradinariu (Principal Investigator, Cardiothoracic Surgery Specialty Registrar, Golden Jubilee National Hospital) — Principal investigator
First posted
May 25, 2022
Start date
Dec 18, 2023
Primary completion
Aug 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Jul 15, 2024

Study contacts

George Gradinariu, MD
principal investigator · Golden Jubilee National Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion